Briefly, CD34+ cells from four CML patients were collected and treated with a single dose of a control chimera, nucleolin aptamer alone, or the nucleolin aptamer-β-arr2A3 chimera and plated in methylcellulose. The gene discussed is NUCLEOLIN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.